FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

(MedPage Today) — The FDA said it has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in patients with congenital thrombotic thrombocytopenic purpura (cTTP) who were treated with the recombinant ADAMTS13…

Source link : https://www.medpagetoday.com/hematologyoncology/hematology/118655

Author :

Publish date : 2025-11-21 20:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

Telehealth-Based Cancer Trial; AI-Based Cancer Biomarkers; Myeloma Survival Landmark

Primary Hyperparathyroidism Tied to Long-Term Cardiometabolic Risks

Related Posts

Menstrual Pain in Sickle Cell Patients: Treatments Available

Metformin vs. Insulin in Pregnancy: Trials Continue

‘Most Favored Nation’ Pricing May Cut Drug Costs. It May Also Cut Off Rural America.

Autism Research Retracted; Alzheimer’s Tau Mismatch; New Functional Seizure Guidance

Third-Generation PCSK9 Inhibitor Approved for High Cholesterol

GLP-1 Microdosing and Longevity; Near 30% Weight Loss in Trial; 2025’s Top Research

Menstrual Pain in Sickle Cell Patients: Treatments Available

Metformin vs. Insulin in Pregnancy: Trials Continue

‘Most Favored Nation’ Pricing May Cut Drug Costs. It May Also Cut Off Rural America.

Autism Research Retracted; Alzheimer’s Tau Mismatch; New Functional Seizure Guidance

Third-Generation PCSK9 Inhibitor Approved for High Cholesterol

GLP-1 Microdosing and Longevity; Near 30% Weight Loss in Trial; 2025’s Top Research

Cardiologist Found Dead; Biological Aging and CVD Risk; New Coronary Clot Retriever

California Hires Ex-CDC Leaders Who Were Fired or Quit Under Trump

Categories

Archives